Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 42.90B | 40.02B | 32.27B | 21.13B | 18.29B |
Gross Profit | 4.52B | 3.25B | 1.22B | -3.98B | -8.57B |
EBITDA | 2.75B | 1.72B | 104.00M | -3.92B | -7.86B |
Net Income | 1.92B | 912.00M | 73.00M | -4.99B | -10.07B |
Balance Sheet | |||||
Total Assets | 24.53B | 23.55B | 21.37B | 20.09B | 32.77B |
Cash, Cash Equivalents and Short-Term Investments | 10.81B | 8.65B | 6.14B | 6.44B | 16.06B |
Total Debt | 3.13B | 5.78B | 3.58B | 4.93B | 10.90B |
Total Liabilities | 20.24B | 20.34B | 19.61B | 18.73B | 26.49B |
Stockholders Equity | 4.29B | 3.22B | 1.76B | 1.36B | 6.28B |
Cash Flow | |||||
Free Cash Flow | 5.16B | 174.00M | -74.00M | -5.27B | -4.13B |
Operating Cash Flow | 5.27B | 529.00M | 122.00M | -5.23B | -3.72B |
Investing Cash Flow | -427.00M | -267.00M | -159.00M | 1.07B | 520.00M |
Financing Cash Flow | -2.65B | 2.17B | -356.00M | -5.72B | 9.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $1.32T | 10.96 | 11.76% | 2.85% | 11.60% | 39.07% | |
76 Outperform | ¥8.34B | 3.03 | ― | 4.79% | 15.19% | ||
72 Outperform | ¥8.00B | 7.35 | 0.48% | 2.99% | 2.07% | ||
71 Outperform | ¥270.65B | 14.28 | 8.44% | 2.84% | 6.34% | 11.66% | |
70 Outperform | ¥7.11B | 7.42 | 2.00% | 1.73% | -61.62% | ||
63 Neutral | ¥1.33T | 8.81 | 2.12% | 8.62% | -0.18% |